Brief: Allarity Therapeutics Reports Third Quarter 2022 Financial Results
15/11/2022 21:09
Nov 15 (Reuters) - Allarity Therapeutics Inc ALLR.O :
* ALLARITY THERAPEUTICS REPORTS THIRD QUARTER 2022 FINANCIAL
RESULTS
* ALLARITY THERAPEUTICS INC - QTRLY BASIC AND DILUTED NET
LOSS PER
COMMON STOCK $0.68
Source text for Eikon: ID:nGNX8KTGkX
Further company coverage: ALLR.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Allarity Therapeutics
See all newsBrief: Allarity Therapeutics Announces Strategic Capital Allocation For Filing Of Spac Registration Statement
Allarity Therapeutics Inc reports results for the quarter ended June 30 - Earnings Summary
Allarity Therapeutics Q2 loss narrows as expenses fall
Allarity Therapeutics Inc expected to post a loss of 25 cents a share - Earnings Preview
Brief: Allarity Therapeutics Announces The Grant Of Essential U.S. Patent For Its Stenoparib Drp® Companion Diagnostic